Latest News

12345678910
AirJoule Has Big Partners—So What’s Still Holding the Stock Back?marketbeat.com
Via MarketBeat · February 23, 2026
Growing Liquidations Lead to 5% Weekend Drop in Shiba Inufool.com
Leverage is working against investors in this key speculative meme coin.
Via The Motley Fool · February 23, 2026
Dow Drops 821 Points On AI, Tariff Concernstalkmarkets.com
Via Talk Markets · February 23, 2026
Uber To Allow Parking Reservations On App With New Acquisitionstocktwits.com
The acquisition is aimed at bringing parking reservations onto the Uber app powered by Spothero, the company said.
Via Stocktwits · February 23, 2026
BWX (NYSE:BWXT) Delivers Impressive Q4 CY2025, Stock Soars
Aerospace and defense company BWX (NYSE:BWXT) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 18.7% year on year to $885.8 million. Its non-GAAP profit of $1.08 per share was 22.2% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
The Roof And Beams Are Creakingtalkmarkets.com
Via Talk Markets · February 23, 2026
10 Dividend Stocks For Perpetually Growing Retirement Incometalkmarkets.com
Via Talk Markets · February 23, 2026
Google Chrome Security Update: Critical Patch Fixes and Bug Improvementstalkmarkets.com
Via Talk Markets · February 23, 2026
Kratos (NASDAQ:KTOS) Delivers Impressive Q4 CY2025
Aerospace and defense company Kratos (NASDAQ:KTOS) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 21.9% year on year to $345.1 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $340 million was less impressive, coming in 0.7% below expectations. Its non-GAAP profit of $0.18 per share was 22.1% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Nutrien Stock in 2026: Buy, Hold, or Sell?https://www.fool.ca/2026/02/23/nutrien-stock-in-2026-buy-hold-or-sell/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=563fe0eb-4a55-4064-8986-82efe04e5dc6
As share prices keep rising since the last few weeks, it might be a good time to consider adding Nutrien (TSX:NTR) stock to your self-directed investment portfolio.
Via The Motley Fool · February 23, 2026
The Smartest Growth Stock to Buy With $1,000 Right Nowhttps://www.fool.ca/2026/02/23/the-smartest-growth-stock-to-buy-with-1000-right-now-17/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=00bc3e1c-21e2-4057-94cf-d94702e55d0c
This under-the-radar battery company is quietly winning Fortune 100 contracts and analysts think the best is yet to come.
Via The Motley Fool · February 23, 2026
Insights into Diversified Healthcare Q4 Earningsbenzinga.com
Via Benzinga · February 23, 2026
Earnings Summary: Atlas Energy Solutions Q4benzinga.com
Via Benzinga · February 23, 2026
Earnings Summary: Boise Cascade Q4benzinga.com
Via Benzinga · February 23, 2026
Better Cryptocurrency to Buy Right Now With $2,000 and Hold for 5 Years: XRP vs. Bitcoinfool.com
These two coins need to accomplish certain objectives to become more valuable, but one faces a more challenging path.
Via The Motley Fool · February 23, 2026
Primoris (NYSE:PRIM) Surprises With Strong Q4 CY2025 But Stock Drops
Infrastructure construction company Primoris (NYSE:PRIM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.7% year on year to $1.86 billion. Its non-GAAP profit of $1.08 per share was 8.9% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Boise Cascade (NYSE:BCC) Exceeds Q4 CY2025 Expectations
Building products company Boise Cascade Company (NYSE:BCC) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 6.8% year on year to $1.46 billion. Its GAAP profit of $0.24 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Erie Indemnity (NASDAQ:ERIE) Misses Q4 CY2025 Revenue Estimates
Insurance management company Erie Indemnity (NASDAQ:ERIE) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 2.9% year on year to $951 million. Its GAAP profit of $1.21 per share was 23.9% below analysts’ consensus estimates.
Via StockStory · February 23, 2026
Primoris Services Q4 Earnings Report: What Investors Need to Knowbenzinga.com
Via Benzinga · February 23, 2026
Bed Bath & Beyond: Q4 Earnings Insightsbenzinga.com
Via Benzinga · February 23, 2026
Plug Power Stock: Dead, or a Future Clean-Energy Beast in the Making?fool.com
Plug Power could benefit from growing demand for green hydrogen, but investors should consider its track record before buying.
Via The Motley Fool · February 23, 2026
Addus HomeCare (NASDAQ:ADUS) Reports Q4 CY2025 In Line With Expectations
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 25.6% year on year to $373.1 million. Its non-GAAP profit of $1.77 per share was 2.6% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Hims & Hers Health’s (NYSE:HIMS) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Telehealth company Hims & Hers Health (NYSE:HIMS) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 28.4% year on year to $617.8 million. On the other hand, next quarter’s revenue guidance of $612.5 million was less impressive, coming in 5.6% below analysts’ estimates. Its GAAP profit of $0.08 per share was 92.5% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
DMC Glb Q4 Earnings Report: What Investors Need to Knowbenzinga.com
Via Benzinga · February 23, 2026
SI-BONE Q4 Earnings Assessmentbenzinga.com
Via Benzinga · February 23, 2026
BWX Technologies Earnings Review: Q4 Summarybenzinga.com
Via Benzinga · February 23, 2026
Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%
Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $209.8 million. The company expects the full year’s revenue to be around $870 million, close to analysts’ estimates. Its non-GAAP profit of $0.04 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 23, 2026
IBM Stock Stung By New Anthropic Tool As Wall Street's AI Jitters Spreadinvestors.com
IBM stock sold off suddenly and sharply Monday as the tech giant became the latest victim to investor fears about Anthropic's AI code.
Via Investor's Business Daily · February 23, 2026
EverQuote (NASDAQ:EVER) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops 10%
Online insurance comparison site EverQuote (NASDAQ:EVER) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 32.5% year on year to $195.3 million. On the other hand, next quarter’s revenue guidance of $180 million was less impressive, coming in 7% below analysts’ estimates. Its GAAP profit of $1.54 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Earnings Breakdown: Backblaze Q4benzinga.com
Via Benzinga · February 23, 2026
SNDK: Is This The Cheapest Stock In All The AI Universe?talkmarkets.com
Via Talk Markets · February 23, 2026
V2X Q4 Earnings Summary & Key Takeawaysbenzinga.com
Via Benzinga · February 23, 2026
This Very Special Income ETFs Has a 13% Yieldhttps://www.fool.ca/2026/02/23/this-very-special-income-etfs-has-a-13-yield/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=7a4b2a77-5d93-4fd1-a1e3-f623ff67f3b0
Global X Canadian Oil and Gas Equity Covered Call ETF (TSX:ENCC) is a covered call ETF income investors should know about.
Via The Motley Fool · February 23, 2026
2 Canadian ETFs to Buy and Hold in a TFSA Foreverhttps://www.fool.ca/2026/02/23/2-canadian-etfs-to-buy-and-hold-in-a-tfsa-forever-2/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=7b7325dd-46ce-4598-b8b8-7c8964351d17
Canadian REIT ETFs pay high but tax-inefficient yields, so a TFSA is the best place to hold them.
Via The Motley Fool · February 23, 2026
The Smartest Growth Stocks to Buy With $1,000 Right Nowfool.com
These two growth stocks are top buys.
Via The Motley Fool · February 23, 2026
American Express Hits Dow Jones On AI Doomsday 'Work Of Fiction'investors.com
American Express stock led the Dow Jones Industrial Average lower as markets gave credence to Citrini Research's 2027 AI recession scenario.
Via Investor's Business Daily · February 23, 2026
Earnings Summary: BioMarin Pharmaceutical Q4benzinga.com
Via Benzinga · February 23, 2026
Insights into Addus HomeCare Q4 Earningsbenzinga.com
Via Benzinga · February 23, 2026
Earnings Breakdown: Innovex International Q4benzinga.com
Via Benzinga · February 23, 2026
Paymentus (NYSE:PAY) Delivers Strong Q4 CY2025 Numbers But Stock Drops
Digital payment platform Paymentus (NYSE:PAY) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 28.1% year on year to $330.5 million. The company expects next quarter’s revenue to be around $335 million, coming in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.20 per share was 22.9% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Why CrowdStrike Plunged For the Second Day In A Rowfool.com
AI disruption fears are leading to indiscriminate sell-offs in specific stocks.
Via The Motley Fool · February 23, 2026
Amazon’s $12B Investment In Louisiana Data Center Buildout To Create More Jobsstocktwits.com
The data center development across Caddo and Bossier Parishes will create 540 full-time jobs, the company said.
Via Stocktwits · February 23, 2026
Here's How Much $1000 Invested In Palo Alto Networks 10 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · February 23, 2026
Why Grail Shares Are Plummetingfool.com
A large clinical trial of the company's cancer screening test did not produce the desired result.
Via The Motley Fool · February 23, 2026
Skyward Specialty Insurance (NASDAQ:SKWD) Surprises With Q4 CY2025 Sales
Specialty insurance provider Skyward Specialty Insurance (NASDAQ:SKWD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 26.7% year on year to $385.6 million. Its non-GAAP profit of $1.17 per share was 14.9% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
JPMorgan Slides As Credit Fears Growbenzinga.com
JPMorgan Chase shares are sharply lower Monday afternoon, falling as investors dumped financials amid a broad sell-off tied to mounting worries over private credit and AI-linked credit risks.
Via Benzinga · February 23, 2026
Options Corner: Reignited Tariff Fears Facilitate A Contrarian Position In Super Micro Computerbenzinga.com
While Super Micro Computer got caught amid recent tariff-related anxieties, the smart money seems relatively confident about SMCI stock.
Via Benzinga · February 23, 2026
AMC Entertainment’s (NYSE:AMC) Q4 CY2025 Sales Top Estimates
Theater company AMC Entertainment (NYSE:AMC) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.29 billion. Its non-GAAP loss of $0.18 per share was 28% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
A 5.6% High-Yield Income ETF That You Can Take to the Bankhttps://www.fool.ca/2026/02/23/a-5-6-high-yield-income-etf-that-you-can-take-to-the-bank/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=228e6122-8bb0-4937-b6b5-e9943cce82e9
Here's why this high-quality ETF, offering a yield of 5.6%, is one of the best investments you can buy for passive income.
Via The Motley Fool · February 23, 2026
This 6% Dividend Stock Pays Cash Each and Every Monthhttps://www.fool.ca/2026/02/23/this-6-dividend-stock-pays-cash-each-and-every-month/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=5133746d-1178-42dc-b30e-f6ad4e1bcc43
This healthcare REIT’s monthly payout looks more supported than it was a year ago, but refinancing and leverage still matter.
Via The Motley Fool · February 23, 2026